BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ji W, Peng Z, Sun B, Chen L, Zhang Q, Guo M, Su C. LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1. Front Oncol 2021;11:678714. [PMID: 34178664 DOI: 10.3389/fonc.2021.678714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Wang X, Ding Y, Hui N, Su B, Yang M. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Eur J Med Res 2022;27:216. [DOI: 10.1186/s40001-022-00854-1] [Reference Citation Analysis]
2 Wang X, Xing Z, Chen H, Yang H, Wang Q, Xing T. High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma. Front Oncol 2022;12:953529. [DOI: 10.3389/fonc.2022.953529] [Reference Citation Analysis]
3 Shen L, Gu P, Qiu C, Ding WT, Zhang L, Cao WY, Li ZY, Yan B, Sun X. Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway. Ann Hepatol 2022;27:100680. [PMID: 35108614 DOI: 10.1016/j.aohep.2022.100680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]